Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 28 studies | 28% ± 9% | |
memory B cell | 17 studies | 28% ± 8% | |
naive B cell | 14 studies | 22% ± 6% | |
germinal center B cell | 4 studies | 46% ± 15% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 18% ± 4% | |
plasma cell | 3 studies | 25% ± 2% | |
precursor B cell | 3 studies | 22% ± 7% | |
GABAergic neuron | 3 studies | 30% ± 7% | |
glutamatergic neuron | 3 studies | 33% ± 9% | |
gamma-delta T cell | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 683.77 | 652 / 653 | 98% | 15.52 | 590 / 605 |
prostate | 100% | 875.01 | 245 / 245 | 97% | 5.22 | 486 / 502 |
bladder | 100% | 726.38 | 21 / 21 | 87% | 7.64 | 438 / 504 |
kidney | 100% | 564.88 | 89 / 89 | 87% | 6.16 | 780 / 901 |
ovary | 92% | 320.07 | 165 / 180 | 93% | 6.35 | 400 / 430 |
uterus | 99% | 634.73 | 169 / 170 | 85% | 6.31 | 388 / 459 |
brain | 99% | 1458.21 | 2606 / 2642 | 83% | 4.42 | 583 / 705 |
lung | 89% | 273.64 | 512 / 578 | 93% | 7.32 | 1069 / 1155 |
breast | 81% | 439.26 | 373 / 459 | 97% | 16.33 | 1079 / 1118 |
stomach | 96% | 399.28 | 343 / 359 | 77% | 5.70 | 220 / 286 |
esophagus | 89% | 391.63 | 1280 / 1445 | 79% | 4.56 | 145 / 183 |
intestine | 93% | 608.86 | 903 / 966 | 69% | 4.33 | 366 / 527 |
adrenal gland | 67% | 145.67 | 174 / 258 | 67% | 2.81 | 154 / 230 |
skin | 67% | 296.02 | 1210 / 1809 | 53% | 3.19 | 250 / 472 |
pancreas | 25% | 46.78 | 81 / 328 | 90% | 5.80 | 160 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 12.52 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 70.82 | 29 / 29 |
spleen | 100% | 1320.94 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.49 | 1 / 1 |
blood vessel | 98% | 637.24 | 1304 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 5.58 | 42 / 45 |
peripheral blood | 80% | 1330.22 | 741 / 929 | 0% | 0 | 0 / 0 |
adipose | 60% | 191.45 | 717 / 1204 | 0% | 0 | 0 / 0 |
heart | 47% | 99.89 | 404 / 861 | 0% | 0 | 0 / 0 |
liver | 4% | 5.80 | 8 / 226 | 36% | 1.79 | 145 / 406 |
muscle | 5% | 10.08 | 42 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031083 | Cellular component | BLOC-1 complex |
GO_0005737 | Cellular component | cytoplasm |
Gene name | BCAS4 |
Protein name | Breast carcinoma-amplified sequence 4 Breast carcinoma amplified sequence 4 |
Synonyms | hCG_1654299 |
Description | |
Accessions | ENST00000358791.9 [Q8TDM0-1] ENST00000609336.5 ENST00000371608.8 A0A804CEY2 A0A0C4DGS6 H7C4Y8 ENST00000463943.1 A0A0C4DH49 ENST00000445038.5 Q8TDM0 |